FDA
-
-
-
-
-
-
-
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine gets approval to expand alcohol disorder trial in Israel
-
-
-
-
-
-
-
Clearmind Medicine Announces Successful Pre-Clinical Results in MEAI Treatment for Alcohol Consumption
-
-
-
323,630 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

